Aethlon Medical prices $4.7M public offering of common stock and warrants at $0.58 per unit

AETHLON MEDICAL INC

Gross proceeds ~$4.7M; net proceeds ~$3.84M after placement agent fees and expenses.
Offering consists of 8.1M shares (or pre-funded warrants) plus Class A and B warrants to buy 8.1M shares each, all at $0.58 per unit.
Class A warrants expire in 5 years, Class B in 1 year; pre-funded warrants exercisable at $0.001 per share.
Maxim Group LLC acted as exclusive placement agent with 6.5% cash fee plus $100K expense reimbursement.
Net proceeds to fund clinical trials, R&D, capex, and working capital.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.